Abstract
It is estimated that about 30 to 40% of couples seeking fertility treatments are diagnosed with male factor infertility. These males have a range of gonadal dysfunctions which include azoospermia (i.e., no sperm in the ejaculate); oligozoospermia (i.e. sperm count less than 20 million/ml), asthenozoospermia (i.e.sperm motility less than 50%) and teratozoospermia (i.e. sperm with normal morphology less than 30%). The group of patients with azoospermia represent about 25% of the total and, of these, about 30% have an obstructive process (obstructive azoospermia) while the remaining have a primary testicular failure (non-obstructive azoospermia). In the obstructive azoospermia group, 25% of males have congenital bilateral absence of the vas deferens (CBAVD), while the incidence among all infertile males is about 2%. In the USA, it is estimated that approximately 16000 males are affected by CBAVD. Anatomically, CBAVD is a disorder characterized by regression bilaterally of variable portions of the epididymis, vas deferens, and, in about 80% of cases, absence of the seminal vesicles. In about 10 to 20% of the patients, a renal anomaly is also present. These anatomical hallmarks are so strikingly similar to those observed in men with cystic fibrosis (CF) that, as early as 1971 (Holsclaw et al. 1971), these two apparently unrelated disorders were hypothesized to have the same genetic origin. The hypothesis was proven when mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene (Kerem et al. 1989; Riordan et al. 1989;Rommens et al. 1989) were found in patients with CF as well patients with isolated CBAVD (Dumur et al. 1990; Anguiano et al. 1992; Patrizio et al. 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Anguiano A, Oates RD, Amos JA et al (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. J Am Med Assoc 267: 1794–1797
Bienvenu T, Adjiman M, Thiounn N et al (1995) Molecular diagnosis of congenital bilateral absence of vas deferens: analyses of the CFTR gene in 64 French patients. Ann Genet 40: 5–9
Castellani C, Bonizzato A, Mastella G (1997) CFTR mutations and IVS8–5T variant in newborns with hypertrypsinaemia and normal sweat test. J Med Genet 34 (4): 297–301
Charny CW and Gillenwater JY (1965) Congenital absence of the vas deferens. J Urol 93: 399–402
Chillon M, Casals T, Mercier B et al (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332: 1475–1480
Costes B, Girodon E, Ghanem N et al (1995) Frequent occurrence of the CFTR intron 8 (TG) 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet 3: 285–293
Dork T, Dworniczak B, Aulehla-Scholz C et al (1997) Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 100: 365–377
Durieu I, Bey-Omar F, Rollet Jet al (1995) Diagnostic criteria for cystic fibrosis in men with congenital absence of the vas deferens. Medicine 74: 42–47
Dumur V, Gervais R, Rigot JM et al (1990) Abnormal distribution of CF AF508 allele in azoospermic men with congenital aplasia of the epididymis and vas deferens. Lancet 336: 512 (letter)
Dumur V, Gervais R, Rigot JM et al (1996) Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype. Hum Genet 97: 7–10
Estivill X (1996) Complexity in a monogenic disease. Nature Genet 12: 348–350
Friedman KJ, Heim RA, Knowles MR, Silverman LM (1997) Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease. Hum Mutat 10 (2): 108–115
Gervais R, Dumur V, Letombe B et al (1996) Hypofertility with thick cervical mucus: another mild form of cystic fibrosis? J Am Med Assoc 276: 1638 (letter)
Harris A and Coleman L (1989) Ductal epithelial cells cultured from human foetal epididymis and vas deferens: relevance to sterility in cystic fibrosis. J Cell Sci 92: 687–690
Hayslip CC, Hao E, Usala SJ (1997) The cystic fibrosis transmembrane regulator gene is expressed in the human endocervix throughout the menstrual cycle. Fertil Steril 67 (4): 636–640
Holsclaw DS, Lobel B, Jockin H, Schwachman H (1971) Genital abnormalities in male patients with cystic fibrosis. J Urol 106: 568–574
Jarvi K, Zieleinski J, Wilschanski M et al (1995) Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 345: 1578 (letter)
Kerem B, Rommens JM, Buchanan JA et al (1989)Identification of the cystic fibrosis gene: genetic analysis. Science 245: 1073–1080
Kerem E, Rave-Harel N, Augarten A et al (1997) A cystic fibrosis transmembrane regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Resp & Crit Care Med 155 (6): 1914–1920
Lissens W, Mercier B, Tournaye H et al (1996) Cystic fibrosis and infertility caused by congenital absence of the vas deferens and related clinical entities. Hum Reprod 11 (suppl 4): 55–78
Patrizio P, Silber SJ, Ord T et al (1988) Two births after microsurgical epididymal sperm aspiration in congenital absence of the vas deferens. Lancet 2: 1364 (letter)
Patrizio P, Asch RH, Handelin B,Silber SJ (1993) Aetiology of congenital absence of the vas defer-ens: genetic study of three generations. Hum Reprod 8: 215–220
Patrizio P, Ord T, Silber SJ, Asch RH (1994) Correlation between epididymal length and fertilization rate in men with congenital absence of the vas deferens. Fertil Steril 61 (2): 265–268
Patrizio P and Zielenski J (1996) Congenital absence of the vas deferens: A mild form of cystic fibrosis. Mol Med Today 2 (1): 24–31
Patrizio P and Salameh WA (1998) Expression of cystic fibrosis transmembrane conductance regulator (CFTR) mRNA in natural and pathological adult human epididymis. J Reprod Fertil (53): 261–270
Rozmahel R, Wilschanski M, Matin A et al (1996) Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet 12: 280–287
Riordan JR, Rommens JM, Kerem BS et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066–1073
Rommens JM, Iannuzzi, MC, Kerem BS et al (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245: 1059–1065
Silber SJ,Patrizio P, Asch RH (1990) Quantitative evaluation of spermatogenesis by testicular histology in men with congenital absence of the vas deferens. Hum Reprod 5: 89–93
Silber SJ, Nagy Z, Liu J et al (1995) The use of epididymal and testicular spermatozoa for intra-cytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod 10: 2031–2043
Tizzano EF, Silver MM, Chitayat D et al (1994) Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol 144: 906–914
Tournaye H, Devroey P, Liu J et al (1994) Microsurgical epididymal sperm aspiration and intra-cytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. Fertil Steril 61: 1045–1051
Zielenski J, Patrizio P, Corey M et al (1995) CFTR gene variant for patients with congenital absence of the vas deferens. Am J Hum Genet 57: 958–960
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Patrizio, P., Leonard, D.G.B. (2000). Mutations of the Cystic Fibrosis Gene and Congenital Absence of the Vas Deferens. In: McElreavey, K. (eds) The Genetic Basis of Male Infertility. Results and Problems in Cell Differentiation, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48461-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-48461-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-08554-3
Online ISBN: 978-3-540-48461-5
eBook Packages: Springer Book Archive